In the BioHarmony Drug Report Database

"Preview" Icon

Triamcinolone

Aristocort, Kenacort (triamcinolone) is a small molecule pharmaceutical. Triamcinolone was first approved as Aristocort on 1982-01-01. It is used to treat adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor.

 

Trade Name

 

Aristocort, Kenacort
 

Common Name

 

triamcinolone
 

ChEMBL ID

 

CHEMBL1451
 

Indication

 

adrenal insufficiency, allergic rhinitis perennial, ankylosing spondylitis, atopic dermatitis, berylliosis, bronchial spasm, dermatitis herpetiformis, erythema multiforme, facial dermatoses, foot dermatoses, hand dermatoses, hemolytic anemia, hypercalcemia, inflammation, leg dermatoses, multiple sclerosis, nephrotic syndrome, pemphigus, pulmonary tuberculosis, rheumatic diseases, scalp dermatoses, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
 

Drug Class

 

Steroids (not prednisolone derivatives)

Image (chem structure or protein)

Triamcinolone structure rendering